entity

ADAM10/ADAM17

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ADAM10/ADAM17: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
0Hypotheses
2Analyses
2Outgoing
0Incoming
0Experiments
2Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
TREM2 proteolytic sheddingcausesprocess0.90
PDGFRβregulatesprotein0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

What blood-brain barrier permeability changes serve as early biomarkers for neur

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.745

How does APOE4's beneficial immune function reconcile with its established role

neurodegeneration | 2026-04-14 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

What blood-brain barrier permeability changes serve as early biomarkers for neur

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

This study shows APOE4 carriers have enhanced beneficial innate immune responses

closed · Rounds: 4 · Score: 0.60 · 2026-04-16

Related Research

Hypotheses and analyses mentioning ADAM10/ADAM17 in their description or question text

No additional research found